Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Sangamo enters agreement with Zeneca for identification of novel gene targets

Nov. 10, 1998

MitoKor and Pfizer to collaborate on mitochondrial targets for neurodegenerative diseases

Nov. 10, 1998

Corixa invests in, works with ImmGenics to develop high-potency monoclonal antibodies

Nov. 9, 1998

Dutch research group focuses attention on adenosine A3 receptor ligands

Nov. 5, 1998

Step taken toward European protection for AltaRex's fundamental technology platform

Nov. 5, 1998

GenVec receives expanded patent coverage in field of gene therapy

Nov. 4, 1998

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Nov. 4, 1998

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

ArQule, Roche Bioscience amend R&D agreement

Nov. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...